Skip to main content

Table 1 Baseline clinical characteristics of SAVR vs TAVI patients

From: Determinants of clinical improvement after surgical replacement or transcatheter aortic valve implantation for isolated aortic stenosis

 

SAVR (n = 45)

TAVI (n = 42)

p-value

Age (years) [Me (P25-P75)]

73 (68 - 78)

83.5 (79 - 87)

<0.001

Female gender [n(%)]

28 (62.2)

26 (61.9)

0.976

BSA ( m 2 ) [Me (P25-P75)]

1.76 (1.57 - 1.86)

1.75 (1.6 - 1.8)

0.639

Hypertension [n(%)]

28 (62.2)

35 (83.3)

0.028

Diabetes mellitus [n(%)]

13 (28.9)

11 (26.2)

0.778

Dislipidemia [n(%)]

28 (62.2)

26 (61.9)

0.976

COPD [n(%)]

12 (26.7)

19 (45.2)

0.071

PAD [n(%)]

3 (6.7)

12 (28.6)

0.007

Atrial Fibrilation [n(%)]

0 (0)

7 (16.7)

0.004

Logistic Euroscore

6.18 ± 2.71

17.86 ± 9.55

<0.001

NYHA class III - IV [n(%)]

12 (26.7)

37 (88.1)

<0.001

  1. BSA = body surface area; COPD = chronic obstructive pulmonary disease; PAD = peripheral artery disease; NYHA = New York Heart Association; values are mean ± SD or median (P25-P75) according to distribution, or n (%).